Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference
LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus
Xceed Meets HTX/CIHR Grant Milestone: Decreasing Sample-Prep Time From Days to Less Than Eight Hours
Tobira Therapeutics Inc. Announces Key Addition to Scientific Advisory Board
Optimal Reading Services Group, Inc. Receives Investment from Health Evolution Partners
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.